OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers
Recruiting
Phase 4
Interventional Study
Marginal Ulcer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 122 (estimated)
- Sponsor
- Stephen Firkins · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to identify the most effective way to take acid-blocking medications to treat stomach ulcers in patients who have undergone gastric bypass surgery. The main questions it aims to answer are:
* is taking an acid-blocking medication by opening the capsule and only taking the contents of the capsule (open-capsule) more or less effective than taking the capsule as a …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Subjects diagnosed with marginal ulceration post-gastric bypass on upper endoscopy
Exclusion Criteria:
* Refusal to start PPI medication OR current open-capsule PPI use at the time of diagnosis of the marginal ulcer
Contacts